BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23731273)

  • 21. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China.
    Liu Q; Yin M; Li G
    Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody.
    Jo K; Kim MH; Lim Y; Jung SL; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
    Eur J Endocrinol; 2015 Oct; 173(4):489-97. PubMed ID: 26208979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.
    Lupoli GA; Okosieme OE; Evans C; Clark PM; Pickett AJ; Premawardhana LD; Lupoli G; Lazarus JH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):100-8. PubMed ID: 25322272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer.
    Jo K; Lim DJ
    Korean J Intern Med; 2018 Nov; 33(6):1050-1057. PubMed ID: 30396251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.
    Kim SS; Lee BJ; Lee JC; Song SH; Kim BH; Son SM; Kim IJ; Kim YK; Kang YH
    Endocrine; 2011 Jun; 39(3):259-65. PubMed ID: 21161440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.
    Spencer C; LoPresti J; Fatemi S
    Curr Opin Endocrinol Diabetes Obes; 2014 Oct; 21(5):394-404. PubMed ID: 25122493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.
    Rubello D; Girelli ME; Casara D; Piccolo M; Perin A; Busnardo B
    J Endocrinol Invest; 1990 Oct; 13(9):737-42. PubMed ID: 2292657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.
    Chung JK; Park YJ; Kim TY; So Y; Kim SK; Park DJ; Lee DS; Lee MC; Cho BY
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):215-21. PubMed ID: 12153600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
    Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
    Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of
    Pan M; Li Z; Jia M; Lu X
    Front Endocrinol (Lausanne); 2022; 13():857057. PubMed ID: 35464061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
    Spencer CA; Takeuchi M; Kazarosyan M; Wang CC; Guttler RB; Singer PA; Fatemi S; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1121-7. PubMed ID: 9543128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
    Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
    Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
    Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different Thyroidal Responses to Human Chorionic Gonadotropin Under Different Thyroid Peroxidase Antibody and/or Thyroglobulin Antibody Positivity Conditions During the First Half of Pregnancy.
    Hou Y; Liu A; Li J; Wang H; Yang Y; Li Y; Fan C; Zhang H; Wang H; Ding S; Teng W; Shan Z
    Thyroid; 2019 Apr; 29(4):577-585. PubMed ID: 30808250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of endogenous TgAb upon serum Tg measurement results and Tg positive rate in patients with differentiated thyroid carcinoma].
    Zhang W; Deng H; Pan M; Huang R; Tang G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Aug; 30(4):803-7. PubMed ID: 24059060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
    Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
    Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PRE-ABLATION THYROGLOBULIN AND THYROGLOBULIN TO THYROID-STIMULATING HORMONE RATIO MAY BE ASSOCIATED WITH PULMONARY METASTASES IN CHILDREN WITH DIFFERENTIATED THYROID CANCER.
    Livhits MJ; Pasternak JD; Xiong M; Li N; Gosnell JE; Yeh MW; Chiu HK
    Endocr Pract; 2016 Nov; 22(11):1259-1266. PubMed ID: 27482611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Response of thyroglobulin, anti-thyroglobulin antibodies, TSH, FT4 and total T3 after rhTSH stimulation in differentiated thyroid carcinoma].
    Moreno Ortega E; Vallejo Casas JA; Mena Bares LM; del Real Núñez R; Maza Muret FR; Hidalgo Ramos FJ; Latre Romero JM
    Rev Esp Med Nucl; 2008; 27(4):253-8. PubMed ID: 18682151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer.
    Neshandar Asli I; Siahkali AS; Shafie B; Javadi H; Assadi M
    Mol Imaging Radionucl Ther; 2014 Jun; 23(2):54-9. PubMed ID: 24963446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.